UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1341-1350

2004

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

Annals of internal medicine, 1998-04, Vol.128 (7), p.541

1998

Volltextzugriff (PDF)

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

British journal of cancer, 2000-05, Vol.82 (10), p.1702-1708

2000

Volltextzugriff (PDF)

Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin

Journal of thrombosis and haemostasis, 2004-02, Vol.2 (2), p.306-312

2004

Volltextzugriff (PDF)

Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1236-1245

2018

Volltextzugriff (PDF)

Reassessing the Hemostatic Disorder Associated With Acute Promyelocytic Leukemia

Blood, 1992-02, Vol.79 (3), p.543-553

1992

Volltextzugriff (PDF)

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin

Cancer research (Chicago, Ill.), 1996-11, Vol.56 (21), p.4887-4890

1996

Volltextzugriff (PDF)

A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

The FASEB journal, 2000-07, Vol.14 (10), p.1400-1410

2000

Volltextzugriff (PDF)

Thrombogenic role of cells undergoing apoptosis

British journal of haematology, 2001-11, Vol.115 (2), p.382-391

2001

Volltextzugriff (PDF)

The Hyperviscosity Syndromes

Seminars in thrombosis and hemostasis, 1999-01, Vol.25 (2), p.199-208

1999

Volltextzugriff (PDF)

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

The Journal of clinical investigation, 1995-12, Vol.96 (6), p.2593-2600

1995

Volltextzugriff (PDF)

Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

Seminars in hematology, 1997-04, Vol.34 (2), p.140-147

1997

Volltextzugriff (PDF)

PB1356 Intrinsic Platelet Dysfunction in Patients with Acute Intracerebral Hemorrhage

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101513, Article 101513

2023

Volltextzugriff (PDF)

The Mechanism of Cancer-Mediated Conversion of Plasminogen to the Angiogenesis Inhibitor Angiostatin

Proceedings of the National Academy of Sciences - PNAS, 1997-09, Vol.94 (20), p.10868-10872

1997

Volltextzugriff (PDF)

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

Haematologica (Roma), 2010-09, Vol.95 (9), p.1555-1562

2010

Volltextzugriff (PDF)

Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1190-1193

2013

Volltextzugriff (PDF)

Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

Seminars in hematology, 1997-04, Vol.34 (2), p.159-166

1997

Volltextzugriff (PDF)

The plasminogen-plasmin system in malignancy

Cancer and metastasis reviews, 1992-11, Vol.11 (3-4), p.291-311

Kwaan, H C

1992

Volltextzugriff (PDF)

Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes

Diabetes (New York, N.Y.), 1992-10, Vol.41 Suppl 2 (Supplement_2), p.32-35

Kwaan, H C

1992

Volltextzugriff (PDF)

Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2571-2574

2010

Volltextzugriff (PDF)

A Highly Conserved Yet Flexible Linker Is Part of a Polymorphic Protein-Binding Domain in Myosin-Binding Protein C

Structure (London), 2016-11, Vol.24 (11), p.2000-2007

2016

Volltextzugriff (PDF)

Thrombotic Microangiopathy Manifesting as Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome in the Cancer Patient

Seminars in thrombosis and hemostasis, 1999-01, Vol.25 (2), p.217-221

1999

Volltextzugriff (PDF)

Thrombotic Microangiopathy in the Cancer Patient

Acta haematologica, 2001-01, Vol.106 (1-2), p.52-56

2001

Volltextzugriff (PDF)

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

Cancer research (Chicago, Ill.), 1994-02, Vol.54 (4), p.1105-1108

1994

Volltextzugriff (PDF)

PB1175 Resonant Acoustic Rheometry (RAR) for the Characterization of Hemostatic Properties Compared to von Clauss Fibrinogen and TEG 6 s Functional Fibrinogen

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100955, Article 100955

2023

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(230)
Humans
(224)
Life Sciences & Biomedicine
(220)
Male
(99)
Biological And Medical Sciences
(89)
Medical Sciences
(82)
Middle Aged
(72)
Female
(71)
Hematology
(65)
Animals
(55)
Cardiovascular System & Cardiology
(49)
Aged
(46)
Fibrinolysis
(46)
Surgery
(46)
Peripheral Vascular Disease
(44)
Adult
(42)
General & Internal Medicine
(31)
Rats
(29)
Medicine, General & Internal
(27)
Hematologic And Hematopoietic Diseases
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin

Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation

Reassessing the Hemostatic Disorder Associated With Acute Promyelocytic Leukemia

Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin

A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

Thrombogenic role of cells undergoing apoptosis

The Hyperviscosity Syndromes

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

PB1356 Intrinsic Platelet Dysfunction in Patients with Acute Intracerebral Hemorrhage

The Mechanism of Cancer-Mediated Conversion of Plasminogen to the Angiogenesis Inhibitor Angiostatin

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome

The plasminogen-plasmin system in malignancy

Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes

Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

A Highly Conserved Yet Flexible Linker Is Part of a Polymorphic Protein-Binding Domain in Myosin-Binding Protein C

Thrombotic Microangiopathy Manifesting as Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome in the Cancer Patient

Thrombotic Microangiopathy in the Cancer Patient

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors

PB1175 Resonant Acoustic Rheometry (RAR) for the Characterization of Hemostatic Properties Compared to von Clauss Fibrinogen and TEG 6 s Functional Fibrinogen

Suchergebnisse filtern